Narrative updates are currently in beta.

Back to narrative

Update shared on09 Aug 2025

Fair value Decreased 11%
AnalystConsensusTarget's Fair Value
US$11.00
44.2% undervalued intrinsic discount
15 Aug
US$6.14
Loading
1Y
-30.1%
7D
2.8%

A downward revision in Xperi’s future P/E and revenue growth forecasts reflects tempered growth expectations, resulting in the consensus analyst price target declining from $12.33 to $11.00.


What's in the News


  • Xperi Inc. reiterated full-year 2025 revenue guidance of $440 million to $460 million.
  • The company previously lowered its 2025 revenue outlook from $480 million–$500 million to $440 million–$460 million.
  • Xperi Inc. was added to the Russell 2000 Value-Defensive Index.
  • The company was also added to the Russell 2000 Defensive Index.

Valuation Changes


Summary of Valuation Changes for Xperi

  • The Consensus Analyst Price Target has significantly fallen from $12.33 to $11.00.
  • The Future P/E for Xperi has fallen from 10.16x to 9.42x.
  • The Consensus Revenue Growth forecasts for Xperi has fallen from 2.6% per annum to 2.5% per annum.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.